Free Trial

Belite Bio (BLTE) News Today

Belite Bio logo
$66.84 -0.01 (-0.01%)
As of 03/28/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Belite Bio, Inc. Appoints New Auditor
Belite Bio price target raised to $80 from $79 at Benchmark
Belite Bio, Inc stock logo
Belite Bio (NASDAQ:BLTE) Shares Gap Up - Here's What Happened
Belite Bio (NASDAQ:BLTE) Shares Gap Up - What's Next?
Belite Bio, Inc stock logo
Benchmark Reiterates Buy Rating for Belite Bio (NASDAQ:BLTE)
Benchmark reissued a "buy" rating and issued a $80.00 target price on shares of Belite Bio in a research note on Wednesday.
Belite Bio's (BLTE) Buy Rating Reaffirmed at Benchmark
Q1 Earnings Forecast for Belite Bio Issued By HC Wainwright
Belite Bio, Inc stock logo
FY2025 EPS Forecast for Belite Bio Decreased by Analyst
Belite Bio, Inc (NASDAQ:BLTE - Free Report) - Analysts at Cantor Fitzgerald lowered their FY2025 EPS estimates for shares of Belite Bio in a research note issued on Tuesday, March 18th. Cantor Fitzgerald analyst J. Kim now expects that the company will post earnings per share of ($1.36) for the y
Belite Bio, Inc stock logo
Equities Analysts Issue Forecasts for Belite Bio Q1 Earnings
Belite Bio, Inc (NASDAQ:BLTE - Free Report) - Research analysts at HC Wainwright reduced their Q1 2025 earnings per share (EPS) estimates for Belite Bio in a report issued on Tuesday, March 18th. HC Wainwright analyst Y. Chen now anticipates that the company will post earnings of ($0.37) per shar
Analysts Issue Forecasts for Belite Bio FY2025 Earnings
Belite Bio, Inc stock logo
Belite Bio, Inc (NASDAQ:BLTE) Short Interest Update
Belite Bio, Inc (NASDAQ:BLTE - Get Free Report) was the target of a large growth in short interest in February. As of February 28th, there was short interest totalling 81,300 shares, a growth of 17.1% from the February 13th total of 69,400 shares. Based on an average trading volume of 46,300 shares, the days-to-cover ratio is currently 1.8 days. Currently, 0.3% of the company's stock are sold short.
Belite Bio, Inc stock logo
Belite Bio's (BLTE) "Overweight" Rating Reaffirmed at Cantor Fitzgerald
Cantor Fitzgerald reiterated an "overweight" rating on shares of Belite Bio in a report on Tuesday.
Belite Bio, Inc stock logo
Belite Bio (NASDAQ:BLTE) Receives Buy Rating from HC Wainwright
HC Wainwright restated a "buy" rating and issued a $100.00 target price on shares of Belite Bio in a research note on Tuesday.
Belite Bio, Inc stock logo
Belite Bio (NASDAQ:BLTE) Shares Gap Down on Disappointing Earnings
Belite Bio (NASDAQ:BLTE) Shares Gap Down After Earnings Miss
Belite Bio, Inc stock logo
Belite Bio (NASDAQ:BLTE) Releases Quarterly Earnings Results, Misses Expectations By $0.02 EPS
Belite Bio (NASDAQ:BLTE - Get Free Report) announced its quarterly earnings data on Monday. The company reported ($0.32) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.30) by ($0.02).
Belite Bio reports Q4 EPS (32c), consensus (31c)
Belite Bio, Inc stock logo
Belite Bio (NASDAQ:BLTE) Stock Price Down 1.6% - What's Next?
Belite Bio (NASDAQ:BLTE) Shares Down 1.6% - Here's What Happened
Belite Bio, Inc stock logo
Belite Bio (NASDAQ:BLTE) Sees Strong Trading Volume - Here's Why
Belite Bio (NASDAQ:BLTE) Sees Strong Trading Volume - What's Next?
Belite Bio, Inc stock logo
Belite Bio (NASDAQ:BLTE) Stock Price Up 4.8% - Here's What Happened
Belite Bio (NASDAQ:BLTE) Trading 4.8% Higher - Here's What Happened
Belite Bio, Inc stock logo
Belite Bio (NASDAQ:BLTE) Trading Up 3.9% - Time to Buy?
Belite Bio (NASDAQ:BLTE) Stock Price Up 3.9% - Should You Buy?
Belite Bio, Inc. ADR (BLTE) Gets a Buy from Benchmark Co.
Belite Bio, Inc stock logo
Belite Bio (BLTE) Expected to Announce Quarterly Earnings on Monday
Belite Bio (NASDAQ:BLTE) will be releasing earnings before the market opens on Monday, March 10, Financial Modeling Prep reports.
Belite Bio, Inc stock logo
Belite Bio (NASDAQ:BLTE) Sees Unusually-High Trading Volume - Should You Buy?
Belite Bio (NASDAQ:BLTE) Sees Strong Trading Volume - Here's What Happened
Belite Bio, Inc stock logo
Belite Bio (NASDAQ:BLTE) Shares Gap Up - Should You Buy?
Belite Bio (NASDAQ:BLTE) Shares Gap Up - Here's Why
Belite Bio announces interim results from DRAGON trial
Belite Bio, Inc stock logo
Belite Bio (NASDAQ:BLTE) Sees Unusually-High Trading Volume - Still a Buy?
Belite Bio (NASDAQ:BLTE) Sees Strong Trading Volume - Still a Buy?
Belite Bio, Inc stock logo
Belite Bio, Inc (NASDAQ:BLTE) Short Interest Down 9.2% in January
Belite Bio, Inc (NASDAQ:BLTE - Get Free Report) was the target of a significant drop in short interest in January. As of January 31st, there was short interest totalling 63,800 shares, a drop of 9.2% from the January 15th total of 70,300 shares. Based on an average trading volume of 59,400 shares, the days-to-cover ratio is currently 1.1 days.
Belite Bio, Inc stock logo
Belite Bio (NASDAQ:BLTE) Trading Up 7.8% - Here's What Happened
Belite Bio (NASDAQ:BLTE) Trading Up 7.8% - Here's What Happened
Belite Bio, Inc stock logo
Belite Bio (NASDAQ:BLTE) Trading Down 4.7% - Should You Sell?
Belite Bio (NASDAQ:BLTE) Shares Down 4.7% - Here's What Happened
Belite Bio: The Picture Is Still Unclear
Belite Bio, Inc stock logo
Belite Bio FY2024 EPS Forecast Lifted by Leerink Partnrs
Belite Bio, Inc (NASDAQ:BLTE - Free Report) - Investment analysts at Leerink Partnrs raised their FY2024 earnings per share (EPS) estimates for shares of Belite Bio in a report issued on Wednesday, January 29th. Leerink Partnrs analyst M. Goodman now expects that the company will post earnings of
Belite Bio, Inc stock logo
JPMorgan Chase & Co. Grows Stock Holdings in Belite Bio, Inc (NASDAQ:BLTE)
JPMorgan Chase & Co. increased its holdings in shares of Belite Bio, Inc (NASDAQ:BLTE - Free Report) by 7,122.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,356 shares of the company's stock after
Belite Bio, Inc stock logo
Belite Bio, Inc (NASDAQ:BLTE) Short Interest Down 60.3% in January
Belite Bio, Inc (NASDAQ:BLTE - Get Free Report) saw a significant drop in short interest in the month of January. As of January 15th, there was short interest totalling 80,400 shares, a drop of 60.3% from the December 31st total of 202,300 shares. Based on an average daily volume of 72,900 shares, the short-interest ratio is currently 1.1 days.
Belite Bio files automatic mixed securities shelf
Belite Bio, Inc stock logo
Belite Bio (NASDAQ:BLTE) Shares Gap Up on Analyst Upgrade
Belite Bio (NASDAQ:BLTE) Shares Gap Up After Analyst Upgrade
Belite Bio, Inc stock logo
Cantor Fitzgerald Forecasts Belite Bio FY2025 Earnings
Belite Bio, Inc (NASDAQ:BLTE - Free Report) - Stock analysts at Cantor Fitzgerald issued their FY2025 earnings per share (EPS) estimates for shares of Belite Bio in a research report issued on Tuesday, January 21st. Cantor Fitzgerald analyst J. Kim forecasts that the company will post earnings of
Remove Ads
Get Belite Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for BLTE and its competitors with MarketBeat's FREE daily newsletter.

BLTE Media Mentions By Week

BLTE Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BLTE
News Sentiment

0.75

0.82

Average
Medical
News Sentiment

BLTE News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BLTE Articles
This Week

7

3

BLTE Articles
Average Week

Remove Ads
Get Belite Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for BLTE and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:BLTE) was last updated on 3/31/2025 by MarketBeat.com Staff
From Our Partners